Analyst Kostas Biliouris from BMO Capital reiterated a Buy rating on Legend Biotech (LEGN – Research Report) and keeping the price target at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback